77 related articles for article (PubMed ID: 17291695)
1. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.
Pugongchai A; Bychkov A; Sampatanukul P
Int J Exp Pathol; 2017 Dec; 98(6):341-346. PubMed ID: 29315911
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk.
Barry KH; Moore LE; Sampson JN; Koutros S; Yan L; Meyer A; Reddy M; Oler AJ; Cook MB; Fraumeni JF; Yeager M; Amundadottir LT; Berndt SI
Br J Cancer; 2017 May; 116(11):1470-1479. PubMed ID: 28463958
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alterations in human prostate cancers.
Nelson WG; De Marzo AM; Yegnasubramanian S
Endocrinology; 2009 Sep; 150(9):3991-4002. PubMed ID: 19520778
[TBL] [Abstract][Full Text] [Related]
6. Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.
Parr RL; Dakubo GD; Crandall KA; Maki J; Reguly B; Aguirre A; Wittock R; Robinson K; Alexander JS; Birch-Machin MA; Abdel-Malak M; Froberg MK; Diamandis EP; Thayer RE
J Mol Diagn; 2006 Jul; 8(3):312-9. PubMed ID: 16825503
[TBL] [Abstract][Full Text] [Related]
7. Re: Genome-Wide Plasma DNA Methylation Features of Metastatic Prostate Cancer.
Atala A
J Urol; 2020 Nov; 204(5):1100-1101. PubMed ID: 32821011
[No Abstract] [Full Text] [Related]
8. Biomarkers in prostate cancer epidemiology.
Verma M; Patel P; Verma M
Cancers (Basel); 2011 Sep; 3(4):3773-98. PubMed ID: 24213111
[TBL] [Abstract][Full Text] [Related]
9. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
[TBL] [Abstract][Full Text] [Related]
10. Multimarker circulating DNA assay for assessing blood of prostate cancer patients.
Sunami E; Shinozaki M; Higano CS; Wollman R; Dorff TB; Tucker SJ; Martinez SR; Mizuno R; Singer FR; Hoon DS
Clin Chem; 2009 Mar; 55(3):559-67. PubMed ID: 19131636
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.
Altimari A; Grigioni AD; Benedettini E; Gabusi E; Schiavina R; Martinelli A; Morselli-Labate AM; Martorana G; Grigioni WF; Fiorentino M
Am J Clin Pathol; 2008 May; 129(5):756-62. PubMed ID: 18426736
[TBL] [Abstract][Full Text] [Related]
12. Firefighting, per- and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk.
Quaid M; Goodrich JM; Calkins MM; Graber JM; Urwin D; Gabriel J; Caban-Martinez AJ; Petroff RL; Grant C; Beitel SC; Littau S; Gulotta JJ; Wallentine D; Hughes J; Burgess JL
Environ Mol Mutagen; 2024; 65(1-2):55-66. PubMed ID: 38523457
[TBL] [Abstract][Full Text] [Related]
13. Promoter Gene Methylation Regulates Clooxygenase-2 Expression in Androgen-Dependent and Independent Prostate Cancer Cells.
Liu CY; Su SH; Chang TH; Hsieh ML; Chang YH; Pang JS; Chuang CK
World J Oncol; 2022 Jun; 13(3):107-116. PubMed ID: 35837323
[TBL] [Abstract][Full Text] [Related]
14. Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis.
Zhou X; Jiao D; Dou M; Chen J; Li Z; Li Y; Liu J; Han X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1939-1948. PubMed ID: 31263949
[TBL] [Abstract][Full Text] [Related]
15. High pesticide exposure events and DNA methylation among pesticide applicators in the agricultural health study.
Rusiecki JA; Beane Freeman LE; Bonner MR; Alexander M; Chen L; Andreotti G; Barry KH; Moore LE; Byun HM; Kamel F; Alavanja M; Hoppin JA; Baccarelli A
Environ Mol Mutagen; 2017 Jan; 58(1):19-29. PubMed ID: 27996157
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and Qualitative Analysis of Circulating Cell-Free DNA Can Be Used as an Adjuvant Tool for Prostate Cancer Screening: A Meta-Analysis.
Yin C; Luo C; Hu W; Ding X; Yuan C; Wang F
Dis Markers; 2016; 2016():3825819. PubMed ID: 27766004
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.
Angulo JC; López JI; Ropero S
Mol Diagn Ther; 2016 Dec; 20(6):531-549. PubMed ID: 27501813
[TBL] [Abstract][Full Text] [Related]
18. When Prostate Cancer Circulates in the Bloodstream.
Vlaeminck-Guillem V
Diagnostics (Basel); 2015 Oct; 5(4):428-74. PubMed ID: 26854164
[TBL] [Abstract][Full Text] [Related]
19. Circulating nucleic acids as biomarkers of prostate cancer.
Sita-Lumsden A; Fletcher CE; Dart DA; Brooke GN; Waxman J; Bevan CL
Biomark Med; 2013 Dec; 7(6):867-77. PubMed ID: 24266819
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of prostate cancer.
Chin SP; Dickinson JL; Holloway AF
Clin Epigenetics; 2011 Aug; 2(2):151-69. PubMed ID: 22704335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
